Preserving testicular tissue in boys before highly harmful childhood cancer treatment
Tests saving testicular tissue for future fertility in boys facing harmful cancer treatment.
Plain-language title generated from the registry record
Registry title: Male Fertility Preservation Using Cryopreservation of Testicular Tissue Before Highly Gonadotoxic Cancer Treatment
Key facts
- Where
- Basel, Geneva, and Lausanne, SwitzerlandSee the 3 sites
Where in Switzerland
- UKBBBasel, SwitzerlandTaking people
- Geneva University HospitalsGeneva, SwitzerlandTaking people
- CHUVLausanne, SwitzerlandTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Gumy-Pause Fabienne
- Trial code
- NCT03180918
- Record updated
- 27 May 2026
- Original description
Background:Read full original descriptionShow less
Male Fertility Preservation Using Cryopreservation of Testicular Tissue Before Highly Gonadotoxic Cancer Treatment
Background:
Due to the remarkable improvement in treatments these last decades, long term survival can be expected in more than 80% of childhood cancer patients. Unfortunately, cancer treatments can be harmful to the gonads and can affect reproductive and endocrine functions. While loss of fertility is a major concern for most patients, sperm cryopreservation should be offered to all pubertal male patients. For prepubertal boys, only the experimental option of testicular biopsy in order to cryopreserve testicular stem cells can be proposed.
Primary aims
- To cryopreserve testicular tissue of prepubertal patient receiving highly gonadotoxic oncological treatment.
Secondary aims
* To cryopreserve testicular tissue after failure of sperm cryopreservation in pubertal patient with high risk of infertility * To create a database in order to record clinical and biological follow-up data * To create a research biobank for future research projects
Multicentric study: HUG, CHUV, UKBB
Inclusion: Prepubertal patients aged 3 months and older; Peri and pubertal patients after failure of sperm cryopreservation; Patients presenting high risk of infertility because of gonadotoxic treatments (i.e high dose of alkylating agents, testicular irradiation, total body irradiation); Multidisciplinary team consensus in favour of proposition to cryopreserve testicular tissue.
Exclusion: Patients under the age of 3 months; Refusal of the patient and/or his parents; Treatments that are not highly gonadotoxic.